(To see other currencies, click on price)
MORE ABOUT THIS BOOK
Main description:
This book provides the first comprehensive overview on the different aromatase inhibitors. Whereas the first aromatase inhibitors to be used therapeutically could be shown to produce drug-induced inhibition of the enzyme and therapeutic benefits in patients with breast cancer, they were not very potent and lacked specificity. However, second-generation drugs were developed and most recently third-generation inhibitors have evolved which possess remarkable specificity and potency.
Contents:
Background and development of aromatase inhibitors.- Aromatase inhibitors and models for breast cancer.- Clinical pharmacology of aromatase inhibitors.- Clinical studies with exemestane.- Clinical studies with letrozole.- Clinical studies with anastrozole.- The third-generation aromatase inhibitors: a clinical overview.- Lessons from the ArKO mouse.- Possible additional therapeutic uses of aromatase inhibitors
PRODUCT DETAILS
Publisher: Springer (Birkhauser Verlag AG)
Publication date: December, 2007
Pages: 199
Weight: 454g
Availability: Available
Subcategories: Diseases and Disorders, Oncology, Pharmacology
From the same series
V. Craig Jordan
Antonio Guglietta
Mark von Itzstein
Maryann Foote
Henry M. Staines
Munther A. Khamashta
Alexandre Trifilieff
Lars Olbe
V. Craig Jordan
Christoph C. Zielinski
H.-J. Schuurman
Eric Ertel
Michel Pairet
Michael Torzewski
Joseph M. Colacino
Bruce N. Cronstein
David Nutt
Udo Dunzendorfer
Allan R. Ronald
Alexander R. Cools
Erik De Clercq
Jerry J. Buccafusco
Roderick J. Flower
Brian E. Leonard
W. Schönfeld
P. Buckel
Wolfgang Loscher
Pedro D'Orléans-Juste
Yuti Chernajovsky
Maryann Foote
Henry M. Staines
Mark von Itzstein
Christoph C. Zielinski
Kenneth C. Anderson
Phil Skolnick
Yuti Chernajovsky
Francesco M. Veronese
Husseini K. Manji
Jeffrey M. Weinberg
John P. H. Wilding
Jacqueline D. Reeves
Herbert M. Pinedo
Jeffrey M. Weinberg